Research & Publications
Evidence we've published, taught, and defended.
Peer-reviewed work, conference contributions, lecture material, and white papers from the Cogience team — in market access, health economics, HTA, and rare-disease evidence.
-
Doctoral research in Health Economics & Health Care Management
Doctoral work underpinning more than a decade of subsequent advisory practice across market access, pricing, and reimbursement for pharmaceutical and medical-device assets.
-
Pricing & Reimbursement of Medical Devices
Four-year course series for postgraduate students covering global pricing models, reimbursement pathways, payer decision-making, and the medical-device-specific economics that diverge from pharmaceuticals.
-
Rare Disease Interest Group — Steering Committee contributions
Ongoing contribution to the HTAi Rare Disease Interest Group, shaping methodological guidance and convening international discussion on HTA approaches for low-prevalence indications and orphan drugs.
Want to commission research with us?
We deliver white papers, primers, and methodological reviews on EU JCA, rare-disease HTA, and payer evidence strategy.
Book a 30-minute call